Posted Nov. 26, 2012 at 5:37 a.m.
Research Triangle Park, N.C. — GlaxoSmithKline, the U.K.'s biggest drugmaker, plans to buy shares in its publicly traded Indian and Nigerian consumer-products subsidiaries, boosting its stake in businesses that are growing faster than branded pharmaceuticals....Copyright 2013 WRAL Tech Wire. All rights reserved.
GSK to invest $1.4B in shares of India, Nigeria subsidiaries
Post a comment
Print this blog postE-mail blog post
Share
Research Triangle Park, N.C. — GlaxoSmithKline, the U.K.'s biggest drugmaker, plans to buy shares in its publicly traded Indian and Nigerian consumer-products subsidiaries, boosting its stake in businesses that are growing faster than branded pharmaceuticals....Copyright 2013 WRAL Tech Wire. All rights reserved.
Please Log In to add a comment.
Best of TechWire Insider
The Skinny
NC Biotech Center braces for worst as Senate slashes budget, too
ArchiveSocial, a new Durham success story, brings home international award
Durham's high-tech infrastructure, talent lure Virginia company
Lenovo acknowledges layoffs in Morrisville as part of shift to 'PC Plus' strategy
Raleigh-based PRA International eyes public offering
Will lightning strike again for veteran entrepreneur Brian Handly at StepLeader?
Raleigh app developer StepLeader lands $4.4M in first fund raiser
IBM opens Linux center in China, says it will work with Red Hat
Red-hot Raleigh startup WedPics hauls in $1.1M in funding
New Triangle venture capital firm slowly emerging from shadows















